Literature DB >> 9893412

Experimental cross-validation of DSM-IV types of attention-deficit/hyperactivity disorder.

K McBurnett1, L J Pfiffner, E Willcutt, L Tamm, M Lerner, Y L Ottolini, M B Furman.   

Abstract

OBJECTIVE: To examine the discriminant validity of DSM-IV attention-deficit/hyperactivity disorder (ADHD) types by testing the hypothesis that types are associated with specific kinds of functional impairment and to compare overlap of DSM-IV and DSM-III-R ADHD.
METHOD: Consecutive referrals (n = 692) to a pediatric subspecialty clinic for ADHD were classified into 1 of each of the 3 DSM-IV types of ADHD using parent and teacher checklist ratings of ADHD symptoms. The resulting types were compared on clinical correlates and on whether the children also met criteria for DSM-III-R ADHD.
RESULTS: The validity of DSM-IV types was supported by dimension-specific impairment and other distinct correlates. Academic problems aggregated in the 2 types defined by extreme inattention, and externalizing problems aggregated in the 2 types defined by extreme hyperactivity.
CONCLUSION: DSM-IV appeared superior to DSM-III-R in subcategorical homogeneity and in exhaustiveness (ability to classify all apparent cases).

Entities:  

Mesh:

Year:  1999        PMID: 9893412     DOI: 10.1097/00004583-199901000-00015

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  21 in total

1.  Etiology of inattention and hyperactivity/impulsivity in a community sample of twins with learning difficulties.

Authors:  E G Willcutt; B F Pennington; J C DeFries
Journal:  J Abnorm Child Psychol       Date:  2000-04

2.  Validity of the sluggish cognitive tempo, inattention, and hyperactivity symptom dimensions: neuropsychological and psychosocial correlates.

Authors:  José J Bauermeister; Russell A Barkley; José A Bauermeister; José V Martínez; Keith McBurnett
Journal:  J Abnorm Child Psychol       Date:  2012-07

3.  ADHD symptom subtypes in children with pervasive developmental disorder.

Authors:  Kenneth D Gadow; Carla J DeVincent; John Pomeroy
Journal:  J Autism Dev Disord       Date:  2006-02

4.  Neurocognitive functioning in AD/HD, predominantly inattentive and combined subtypes.

Authors:  Mary V Solanto; Sharone N Gilbert; Anu Raj; John Zhu; Sabrina Pope-Boyd; Sa'brina Pope-Boyd; Brenda Stepak; Lucia Vail; Jeffrey H Newcorn
Journal:  J Abnorm Child Psychol       Date:  2007-07-14

5.  The shifting subtypes of ADHD: classification depends on how symptom reports are combined.

Authors:  Andrew S Rowland; Betty Skipper; David L Rabiner; David M Umbach; Lil Stallone; Richard A Campbell; Richard L Hough; A J Naftel; Dale P Sandler
Journal:  J Abnorm Child Psychol       Date:  2008-03-18

Review 6.  Inhibitory functioning across ADHD subtypes: recent findings, clinical implications, and future directions.

Authors:  Zachary W Adams; Karen J Derefinko; Richard Milich; Mark T Fillmore
Journal:  Dev Disabil Res Rev       Date:  2008

7.  Investigating facets of personality in adult pathological gamblers with ADHD.

Authors:  Margarit Davtian; Rory C Reid; Timothy W Fong
Journal:  Neuropsychiatry (London)       Date:  2012-04

8.  Symptom properties as a function of ADHD type: an argument for continued study of sluggish cognitive tempo.

Authors:  K McBurnett; L J Pfiffner; P J Frick
Journal:  J Abnorm Child Psychol       Date:  2001-06

9.  Characteristics of DSM-IV attention deficit hyperactivity disorder combined and predominantly inattentive subtypes in a Turkish clinical sample.

Authors:  Ozgur Oner; Pinar Oner; Esra Cop; Kerim M Munir
Journal:  Child Psychiatry Hum Dev       Date:  2012-08

10.  Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions.

Authors:  Pedro E M S Ferreira; André Palmini; Claiton H D Bau; Eugenio Horacio Grevet; João Rubião Hoefel; Luis Augusto Rohde; Maurício Anés; Eloisa Elena Ferreira; Paulo Belmonte-de-Abreu
Journal:  J Neural Transm (Vienna)       Date:  2009-04-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.